{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:34:43Z","timestamp":1774650883262,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.rpth.2023.100118","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:21:55Z","timestamp":1678713715000},"page":"100118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined oral contraceptives may activate the contact system in healthy women"],"prefix":"10.1016","volume":"7","author":[{"given":"Jesper","family":"Strandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger Lise","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaseelan","family":"Palarasah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen Brodersen","family":"Gram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Risom","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes Jakobsen","family":"Sidelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100118_bib1","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.rpth.2023.100118_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOH.0b013e328309ec85","article-title":"Novel roles for factor XII-driven plasma contact activation system","volume":"15","author":"M\u00fcller","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2023.100118_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1040-8428(86)80053-1","article-title":"The contact activation system: biochemistry and interactions of these surface-mediated defense reactions","volume":"5","author":"Colman","year":"1986","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.rpth.2023.100118_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood.2019002224","article-title":"Protease activity in single-chain prekallikrein","volume":"135","author":"Ivanov","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100118_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jth.15149","article-title":"Proteolytic activity of contact factor zymogens","volume":"19","author":"Shamanaev","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clinbiochem.2016.06.011","article-title":"Calibrated\u00a0kallikrein generation in human plasma","volume":"49","author":"Biltoft","year":"2016","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.rpth.2023.100118_bib7","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2016-10-744110","article-title":"Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation","volume":"129","author":"Ivanov","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100118_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1067\/mai.2002.121316","article-title":"Pathways for bradykinin formation and inflammatory disease","volume":"109","author":"Kaplan","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.rpth.2023.100118_bib10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.biomaterials.2008.12.041","article-title":"Contact activation of blood-plasma coagulation","volume":"30","author":"Vogler","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.rpth.2023.100118_bib11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.bbagen.2015.03.005","article-title":"C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: implication for a role in hereditary angioedema","volume":"1850","author":"Madsen","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.rpth.2023.100118_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII contact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.100118_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-0031-1276586","article-title":"The plasma contact system 2.0","volume":"37","author":"Maas","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.100118_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rpth.2023.100118_bib15","first-page":"1","article-title":"The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis","volume":"2","author":"Baratloo","year":"2014","journal-title":"Emergency"},{"key":"10.1016\/j.rpth.2023.100118_bib16","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2023.100118_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2023.100118_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2023.100118_bib19","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2023.100118_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1365-2141.2001.02853.x","article-title":"Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over","volume":"113","author":"Mackie","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.100118_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.rpth.2023.100118_bib22","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","article-title":"Coagulation effects of oral contraception","volume":"157","author":"Bonnar","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2023.100118_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.rpth.2023.100118_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.100118_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12654","article-title":"Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: assessment of analytical and between-subject variation","volume":"6","author":"Kristensen","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2013.04.012","article-title":"ELISA for determination of total coagulation factor XII concentration in human plasma","volume":"394","author":"Madsen","year":"2013","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.rpth.2023.100118_bib27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1055\/a-1346-3384","article-title":"Effect of anabolic-androgenic steroid abuse on the contact activation system","volume":"121","author":"Sidelmann","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.873975","article-title":"Plasma kallikrein cleaved H-kininogen: an end-point marker for contact activation in\u00a0vitro and ex\u00a0vivo","volume":"9","author":"Palarasah","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2023.100118_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting\u00a0plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.rpth.2023.100118_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-0528.1993.tb12956.x","article-title":"Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill","volume":"100","author":"Campbell","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.rpth.2023.100118_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-0038-1657871","article-title":"Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator","volume":"54","author":"Jespersen","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0049-3848(94)90268-2","article-title":"Contact factors in plasma from women on oral contraception\u2013significance of factor XI for the measured activity of factor XII","volume":"74","author":"Fossum","year":"1994","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100118_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(91)90343-U","article-title":"Contact activation factors in plasma from women using oral contraceptives\u2013increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein","volume":"64","author":"Hoem","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100118_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1047-2797(92)90093-6","article-title":"Estrogen-associated thromboembolism","volume":"2","author":"Wessler","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.rpth.2023.100118_bib35","first-page":"762","article-title":"Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives","volume":"96","author":"Gordon","year":"1980","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.rpth.2023.100118_bib36","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1097\/MD.0000000000000385","article-title":"Comparative study of the effects of combined oral contraceptives in hemostatic variables: an\u00a0observational preliminary study","volume":"94","author":"Stocco","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rpth.2023.100118_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.molimm.2010.05.010","article-title":"The plasma bradykinin-forming pathways and its interrelationships with complement","volume":"47","author":"Kaplan","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.rpth.2023.100118_bib38","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jth.14595","article-title":"Nomenclature of faktor XI and the contact system","volume":"17","author":"Schmaier","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413370","article-title":"High molecular weight kininogen: a Review of the structural literature","volume":"22","author":"Ponczek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2023.100118_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647467","article-title":"Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families","volume":"65","author":"L\u00e4mmle","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1160\/TH04-04-0250","article-title":"Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in\u00a0vivo","volume":"92","author":"Pauer","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib42","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2008.03142.x","article-title":"A\u00a0complete factor XII deficiency does not affect coagulopathy, inflammatory responses, and lethality, but attenuates early hypotension in endotoxemic mice","volume":"6","author":"Iwaki","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib43","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In\u00a0vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100118_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119166","article-title":"An update on factor XII-driven vascular inflammation","volume":"1869","author":"Mailer","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.rpth.2023.100118_bib45","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100118_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00281-021-00876-7","article-title":"The contact system in liver injury","volume":"43","author":"Rangaswamy","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.rpth.2023.100118_bib47","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1182\/bloodadvances.2021005116","article-title":"Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation","volume":"5","author":"Shim","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100118_bib48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2015-01-622811","article-title":"The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis","volume":"126","author":"Nickel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100118_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0049-3848(10)70147-X","article-title":"Factor Xa and thrombin as targets for new oral anticoagulants","volume":"127","author":"Weitz","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100118_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOH.0b013e3283497e61","article-title":"Factor XI and XII as antithrombotic targets","volume":"18","author":"M\u00fcller","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2023.100118_bib51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jth.13005","article-title":"Factor XI and contact activation as targets for antithrombotic therapy","volume":"13","author":"Gailani","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100118_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MOH.0000000000000603","article-title":"The rebirth of the contact pathway: a new therapeutic target","volume":"27","author":"Srivastava","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2023.100118_bib53","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/13543776.2021.1945580","article-title":"Factor XII(a) inhibitors: a review of the patent literature","volume":"31","author":"Kalinin","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.rpth.2023.100118_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1160\/TH11-07-0481","article-title":"Haemostatic variables during normal menstrual cycle. A systematic review","volume":"107","author":"Knol","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:22:43Z","timestamp":1762863763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2475037923000870"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100118","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined oral contraceptives may activate the contact system in healthy women","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100118"}}